2015
DOI: 10.1038/srep13281
|View full text |Cite
|
Sign up to set email alerts
|

Monomeric C-reactive protein-a key molecule driving development of Alzheimer’s disease associated with brain ischaemia?

Abstract: Alzheimer’s disease (AD) increases dramatically in patients with ischaemic stroke. Monomeric C-reactive protein (mCRP) appears in the ECM of ischaemic tissue after stroke, associating with microvasculature, neurons and AD-plaques, Aβ, also, being able to dissociate native-CRP into inflammatory, mCRP in vivo. Here, mCRP injected into the hippocampal region of mice was retained within the retrosplenial tract of the dorsal 3rd ventrical and surrounding major vessels. Mice developed behavioural/cognitive deficits … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

8
89
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 102 publications
(104 citation statements)
references
References 50 publications
8
89
0
1
Order By: Relevance
“…This study assessed the beneficial effects of melatonin treatment on cognition and brain status in NoTg and 3xTg‐AD mice. 3xTg‐AD mice presented impairment of recognition memory evaluated by the NOR test as previously reported . Observations also indicated deterioration in exploratory behavior and increase in anxiety‐like conduct, comprising the BPSD‐like phenotype characteristic of 3xTg‐AD strain .…”
Section: Discussionsupporting
confidence: 80%
“…This study assessed the beneficial effects of melatonin treatment on cognition and brain status in NoTg and 3xTg‐AD mice. 3xTg‐AD mice presented impairment of recognition memory evaluated by the NOR test as previously reported . Observations also indicated deterioration in exploratory behavior and increase in anxiety‐like conduct, comprising the BPSD‐like phenotype characteristic of 3xTg‐AD strain .…”
Section: Discussionsupporting
confidence: 80%
“…Mouse monoclonal antibody to human mcrP sub-unit (M8c10) was obtained from dr L.a, and was stated as previously (2). Mouse monoclonal antibodies to p-tau and β-amyloid were purchased from abcam (UK).…”
Section: Methodsmentioning
confidence: 99%
“…Age is a major non-modifiable risk factor for brain ischemia and AD [29][30][31][32]. The incidence of cerebral ischemia and AD increases significantly with age in both men and women, covering almost the same number of cases occurring in persons over 65 years of age [29].…”
Section: Discussionmentioning
confidence: 99%
“…The incidence of cerebral ischemia and AD increases significantly with age in both men and women, covering almost the same number of cases occurring in persons over 65 years of age [29]. Although the entire older population is at risk of ischemic stroke and AD, there are significant gender differences in the occurrence of brain ischemia and AD [29,32]. In general, the incidence of ischemic stroke is higher in men than in women, but at the same age, the number of cases of AD is higher in women than in men [29].…”
Section: Discussionmentioning
confidence: 99%